• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dexcom Inc (NQ: DXCM )

    68.91 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Dexcom Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    23 24 Next >
    Why DexCom Stock Flopped on Friday
    Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth. 
    Via The Motley Fool
    Analyst Expectations For DexCom's Future
    Via Benzinga
    These Analysts Revise Their Forecasts On DexCom Following Q3 Results
    Via Benzinga
    Nasdaq Up Triple Digits As Stocks Rally, Yields Cool
    Stocks are finishing the week strong, but it's a pyrrhic victory, with two of the three major indexes still staring down sizable weekly losses. 
    Via Talk Markets
    Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
    The major indexes were mixed for the week. 
    Via Investor's Business Daily
    Where Will DexCom Be in 5 Years?
    Recent developments might have scared away some investors, but patience could pay off. 
    Via The Motley Fool
    Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
    Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase. 
    Via Chartmill
    Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
    Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks. 
    Via Benzinga
    Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Looking Into DexCom's Recent Short Interest
    Via Benzinga
    $100 Invested In This Stock 15 Years Ago Would Be Worth $3,600 Today
    Via Benzinga
    $100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
    Via Benzinga
    What the Options Market Tells Us About DexCom
    Via Benzinga
    DexCom (DXCM) Q3 2024 Earnings Call Transcript
    DXCM earnings call for the period ending September 30, 2024. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    DexCom Stock Drops After Q3 Results, Announces C-Suite Transition
    DexCom reported its third-quarter results after Thursday's closing bell. Here's a look at the details from the report. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Dexcom Tops Quarterly Expectations And Keeps Its Guidance. But Shares Crash.
    The company continues to expect 11% to 13% organic sales growth this year. 
    Via Investor's Business Daily
    Jim Cramer Calls AST SpaceMobile 'Overvalued,' Warns HubSpot Is 'Playing With Fire'
    Cheniere Energy (LNG) is a buy, while GE Vernova (GEV) may sell off on good news. HubSpot (HUBS) is risky, NuScale Power (SMR) is losing money, and AST SpaceMobile (ASTS) is overvalued. 
    Via Benzinga
    Is DexCom a Millionaire Maker?
    It isn't the most likely candidate to make someone a millionaire, but it's theoretically possible. 
    Via The Motley Fool
    Tech Stocks Rebound, Tesla Soars To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
    Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    2 Magnificent Stocks to Buy That Are Near 52-Week Lows
    A discounted stock can present an opportunity when there's a quality business behind it. 
    Via The Motley Fool
    Tech Stocks Rebound With Tesla Soaring To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
    Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
    Via Benzinga
    Down More Than 50% From Its High, Is DexCom Stock a Buy?
    Is DexCom's business in trouble, or could this be a great buying opportunity for investors? 
    Via The Motley Fool
    2 Beaten-Down Growth Stocks You Might Regret Not Buying
    Their headwinds won't last forever. 
    Via The Motley Fool
    Is DexCom a Millionaire Maker?
    The company's game-changing technology could improve the lives of hundreds of millions of patients. 
    Via The Motley Fool
    Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
    Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain. 
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Down More Than 50%, Is DexCom Stock a Bargain Now?
    Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market. 
    Via The Motley Fool
    2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
    Sometimes, a discounted stock can present a valuable opportunity. 
    Via The Motley Fool
    DexCom Is Great. Here's Why You Shouldn't Buy It.
    Two key uncertainties make the prospect of buying it today riskier than is desirable. 
    Via The Motley Fool
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    23 24 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.